JP3235922B2 - Cosmetics - Google Patents

Cosmetics

Info

Publication number
JP3235922B2
JP3235922B2 JP27690593A JP27690593A JP3235922B2 JP 3235922 B2 JP3235922 B2 JP 3235922B2 JP 27690593 A JP27690593 A JP 27690593A JP 27690593 A JP27690593 A JP 27690593A JP 3235922 B2 JP3235922 B2 JP 3235922B2
Authority
JP
Japan
Prior art keywords
skin
ethanol
test
activity
active oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP27690593A
Other languages
Japanese (ja)
Other versions
JPH07126143A (en
Inventor
恒雄 難波
征雄 服部
健次 下村
雅美 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP27690593A priority Critical patent/JP3235922B2/en
Publication of JPH07126143A publication Critical patent/JPH07126143A/en
Application granted granted Critical
Publication of JP3235922B2 publication Critical patent/JP3235922B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、美白作用が高く、ヒア
ルロニダーゼの活性を阻害し、且つ肌荒れなどに有効な
安全性の高い化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a highly safe cosmetic which has a high whitening effect, inhibits the activity of hyaluronidase, and is effective for rough skin.

【0002】[0002]

【従来の技術】オオバナサルスベリ(lagerstroemia sp
eciosa)は、ミソハギ科サルスベリ属の植物でインドに
生える半落葉高木である。このオオバナサルスベリの根
は、下痢に、樹皮、葉は下剤として利用されている。
BACKGROUND OF THE INVENTION Lagerstroemia sp.
eciosa) is a semi-deciduous tree that grows in India and is a plant belonging to the genus Lagerstroemia in the family Sorrelidae. The roots of this crab are used for diarrhea, and the bark and leaves are used as laxatives.

【0003】一方、化粧料の原料として使用できる美白
作用のある物質としては、種々の物質が知られている
が、合成品は、長期間人間の肌に適用した場合の安全性
の保証がなく、使用が制限されつつある。他方、天然物
では美白作用が弱いものが多い。しかし、人の肌に対す
る安全性の面から天然物で、多年、人が食したりして、
安全性の面で保証されており、しかも美白作用が強く、
更に皮膚に対する他の効果も合わせもつ物質が望まれて
いた。
[0003] On the other hand, various substances having a whitening effect that can be used as a raw material of cosmetics are known, but synthetic products have no guarantee of safety when applied to human skin for a long time. , Use is being restricted. On the other hand, many natural products have a weak whitening effect. However, it is a natural product from the aspect of safety for human skin, and humans eat it for many years,
It is guaranteed in terms of safety, and has a strong whitening effect,
There is a need for a substance that also has other effects on the skin.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、皮膚
に適用して安全であると共に、美白作用が大きく且つヒ
アルロニダーゼの活性を阻害し、更に肌荒れなどに有効
な成分を含んだ化粧料を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a cosmetic composition which is safe when applied to the skin, has a large whitening effect, inhibits the activity of hyaluronidase, and further contains an effective ingredient for rough skin. To provide.

【0005】[0005]

【課題を解決するための手段】本発明者らは、前記の課
題を解決するために、すでに多年にわたって食用に供さ
れ、人体に対する安全性が確認されている植物をスクリ
ーニングして調べ、化粧料として利用価値のあるものを
検討した。その結果、オオバナサルスベリが化粧品原料
として、或いは医薬部外品としての有効性を有すること
を見い出して本発明を完成するに至ったのである。すな
わち、本発明は、オオバナサルスベリ(lagerstroemia
speciosa)の溶媒抽出物を含む化粧料である。
Means for Solving the Problems In order to solve the above-mentioned problems, the present inventors have screened and examined plants which have been used for food for many years and which have been confirmed to be safe for the human body. We considered something worthwhile. As a result, the present inventors have found that P. persica is effective as a cosmetic raw material or as a quasi-drug, and completed the present invention. That is, the present invention relates to
Speciosa).

【0006】[0006]

【作用】本発明の化粧料として用いられるオオバナサル
スベリの溶媒抽出物の確認された作用は、第1に肌の美
白作用、第2にヒアルロニダーゼの活性抑制作用、第3
に活性酸素抑制作用、第4に抗酸化作用である。上記第
2のヒアルロニダーゼの活性抑制作用について更に詳し
く説明する。ヒアルロニダーゼは、生体中に広く分布
し、皮膚にも存在する酵素であり、その名のとおりヒア
ルロン酸を分解する。ヒアルロン酸は、β−D−N−ア
セチルグルコサミンとβ−D−グルクロン酸が交互に結
合した直鎖状の高分子多糖で、コンドロイチン硫酸など
とともに哺乳動物の結合組織に広く存在するグリコサミ
ノグルカンの一種である。結合組織内でのヒアルロン酸
の作用としては、細胞間隙に水分を保持し、また組織内
にジェリー状のマトリックスを形成して細胞を保持した
り、皮膚の潤滑性と柔軟性を保ち、外力(機械的障害)
および細菌感染を防止していると考えられている。ま
た、皮膚のヒアルロン酸は齢をとるにつれて減少し、そ
の結果小ジワやかさつきなどの老化をもたらすといわれ
ている。従って、このヒアルロン酸を分解するヒアルロ
ニダーゼの活性を抑制することは、製剤に使用されてい
るヒアルロン酸の安定性や、皮膚に塗布した後の製剤の
ヒアルロン酸及び皮膚に存在していたヒアルロン酸の安
定に寄与すると考えられる。
The effects of the solvent extract of C. versicolor to be used as the cosmetic of the present invention are as follows: first, skin whitening effect; second, hyaluronidase activity inhibitory effect;
The fourth is an active oxygen suppressing action, and the fourth is an antioxidant action. The activity suppressing effect of the second hyaluronidase will be described in more detail. Hyaluronidase is an enzyme widely distributed in living organisms and also present on skin, and as its name implies, degrades hyaluronic acid. Hyaluronic acid is a linear high molecular polysaccharide in which β-DN-acetylglucosamine and β-D-glucuronic acid are alternately bonded, and is a glycosaminoglucan widely present in connective tissues of mammals together with chondroitin sulfate and the like. Is a kind of The action of hyaluronic acid in connective tissue is to maintain water in the intercellular space, form a jelly-like matrix in the tissue to hold the cells, maintain the lubricity and flexibility of the skin, Mechanical failure)
And prevent bacterial infection. In addition, it is said that hyaluronic acid in the skin decreases with age, which results in aging such as fine wrinkles and dryness. Therefore, suppressing the activity of the hyaluronidase that degrades this hyaluronic acid, the stability of the hyaluronic acid used in the formulation, the hyaluronic acid of the formulation after application to the skin and the hyaluronic acid present in the skin It is thought to contribute to stability.

【0007】また、上記第3の活性酸素抑制作用につい
て更に詳しく説明する。一般に、空気中に酸素がないと
生物(嫌気性のものを除く)は存在しえない。しかし、
酸素は紫外線や酵素等の影響を受けて活性酸素になる。
この活性酸素は、脂肪酸を酸化し過酸化物を生成させ
る。生体の生体膜のリン脂質も酸化させ、障害を与え
る。その上、生成した過酸化物と活性酸素はDNAに損
傷を与え、老化を促進するといわれている。この活性酸
素は、チロシンからメラニンを作る機構にも影響を与え
皮膚の黒化にも関与している。この活性酸素を抑制する
ことは皮膚にとって重要な、言い換えれば化粧料に求め
られる重要な要素である。
[0007] The third active oxygen suppressing action will be described in more detail. In general, organisms (except anaerobic ones) cannot exist without oxygen in the air. But,
Oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes.
This active oxygen oxidizes fatty acids to form peroxides. Phospholipids in biological membranes of living organisms also oxidize and cause damage. In addition, it is said that the generated peroxide and active oxygen damage DNA and promote aging. This active oxygen affects the mechanism of producing melanin from tyrosine and is also involved in skin darkening. Suppressing this active oxygen is important for the skin, in other words, an important factor required for cosmetics.

【0008】オオバナサルスベリの利用方法としては、
水或いは親水性有機溶媒、例えば、エタノール、メタノ
ール、アセトン等で抽出する。しかしながら、化粧品原
料の抽出であるから、水、或いはエタノール又はこれら
の混合溶媒での抽出が好ましいのは当然である。また、
場合によっては、グリセリン、1,3−ブチレングリコ
ール、プロピレングリコール等の多価アルコール又は多
価アルコールと水の混液も抽出に利用できる。さらにま
た、凍結乾燥して粉体として利用することも利用方法に
よっては有効である。
[0008] As a method of utilizing the sedge beetle,
Extract with water or a hydrophilic organic solvent such as ethanol, methanol, acetone or the like. However, since it is an extraction of cosmetic raw materials, it is natural that extraction with water, ethanol, or a mixed solvent thereof is preferable. Also,
In some cases, a polyhydric alcohol such as glycerin, 1,3-butylene glycol, propylene glycol, or a mixture of polyhydric alcohol and water can also be used for extraction. Furthermore, it is also effective to freeze-dry and use as a powder depending on the method of use.

【0009】この物質を他の化粧品原料、例えば、スク
ワラン、ホホバ油等の液状油、ミツロウ、セチルアルコ
ール等の固体油、各種の活性剤、グリセリン、1,3ー
ブチレングリコール等の保湿剤や各種薬剤等を配合して
様々な剤形の化粧料、例えば、ローション、クリーム、
乳液、パック等、目的に応じて種々の利用形態の化粧料
などに調製することができる。
This substance is used as a raw material for other cosmetics, for example, liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin, 1,3-butylene glycol and various other oils. Various formulations of cosmetics, such as lotions, creams,
It can be prepared into cosmetics in various forms depending on the purpose, such as emulsions and packs.

【0010】[0010]

【実施例】以下に、本発明で使用するオオバナサルスベ
リの抽出物の製造例、実際の利用方法である実施例を記
載するが、本発明はこれらの製造例及び実施例によって
何ら限定されるものではない。
EXAMPLES Examples of the production and practical use of the extract of Prunus brassicae used in the present invention are described below, but the present invention is not limited to these production examples and examples. is not.

【0011】〔製造例1〕オオバナサルスベリの葉(乾
燥品)10gにエタノール300mlを加えて時々撹拌し
つつ5日間放置した。これを濾過後凍結乾燥した。
[Production Example 1] 300 ml of ethanol was added to 10 g of a leaf of Salvia versicolor (dry product), and the mixture was allowed to stand for 5 days with occasional stirring. This was lyophilized after filtration.

【0012】〔製造例2〕オオバナサルスベリの葉(乾
燥品)10gに50%エタノール水溶液300mlを加え
て時々撹拌しつつ5日間放置した。これを濾過後凍結乾
燥した。
[Production Example 2] 300 ml of a 50% aqueous ethanol solution was added to 10 g of a leaf of Salvia versicolor (dry product), and the mixture was left for 5 days with occasional stirring. This was lyophilized after filtration.

【0013】〔製造例3〕オオバナサルスベリの葉(乾
燥品)10gに精製水300mlを加えて3時間加熱す
る。これを放冷した後濾過後凍結乾燥した。
[Production Example 3] 300 ml of purified water was added to 10 g of a leaf of Salvia versicolor (dry product), and the mixture was heated for 3 hours. This was allowed to cool, filtered, and lyophilized.

【0014】〔実施例1(ローションの調製)〕下記の
諸成分を混合して、常法によりローションを調製した。 (重量%) オリーブ油 0.5 製造例1のオオバナサルスベリのエタノール抽出物 0.5 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 2.0 エタノール 10.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 精製水 80.0
Example 1 (Preparation of lotion) The following components were mixed to prepare a lotion according to a conventional method. (% By weight) Olive oil 0.5 Ethanol extract of Prunus brassicae in Preparation Example 0.5 Polyoxyethylene (20E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60E.O.) hydrogenated castor oil 2 0.0 Ethanol 10.0 1.0% aqueous solution of sodium hyaluronate 5.0 Purified water 80.0

【0015】〔実施例2(クリームの調製)〕下記諸成
分からなるAとBとをそれぞれ70℃まで加温し、次い
で、BにAを撹拌しつつ徐々に加えた後、ゆっくりと撹
拌しつつ30℃まで冷却してクリームを調製した。 (重量%) A スクワラン 20.0 オリーブ油 2.0 ミンク油 1.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 製造例2のオオバナサルスベリの50%エタノール抽出物 1.0 B 精製水 47.9 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 パラオキシ安息香酸メチル 0.1
Example 2 (Preparation of a cream) A and B comprising the following components were each heated to 70 ° C., and then A was gradually added to B while stirring, and then slowly stirred. While cooling to 30 ° C., a cream was prepared. (% By weight) A Squalane 20.0 Olive oil 2.0 Mink oil 1.0 Jojoba oil 5.0 Beeswax 5.0 Cetostearyl alcohol 2.0 Glycerin monostearate 1.0 Sorbitan monostearate 2.0 Production example 2 50% Ethanol Extract of P. serrata in Japan 1.0B Purified Water 47.9 Polyoxyethylene (20E.O.) Sorbitan Monostearate 2.0 Polyoxyethylene (60E.O.) Hardened Castor Oil 1.0 Glycerin 5.0 1.0% aqueous solution of sodium hyaluronate 5.0 methyl methyl paraoxybenzoate 0.1

【0016】〔実施例3(ローションの調製)〕実施例
1において製造例1の抽出物を製造例3の抽出物に変え
て調製した。
Example 3 (Preparation of lotion) The extract of Production Example 1 in Example 1 was prepared by changing the extract of Production Example 3.

【0017】〔チロシナーゼ活性阻害〕 (試験方法)マックルバルン(Mcllvaln)緩衝液0.9m
l、1.66mMチロシン(Tyrosine)溶液1.0ml、前記製
造例(凍結乾燥品)の0.1wt/v%水溶液(溶解しにく
い場合はエタノールを加えて溶解したのち精製水を加え
て、エバポレートし、エタノール除去したのち、0.1w
t/v%になるように調製した)1.0mlをスクリューバイ
アルにとり、37℃恒温水槽中で5分以上加温した。チ
ロシナーゼ溶液(Sigma社製、マッシュルーム由来、914
ユニット/ml)0.1mlを加え、37℃恒温水槽中で保温
し、10分後に475nmで吸光度を測定した。対照とし
て、上記試料液のかわりに純水を加え同様に測定した。
この試験では試料の終濃度は0.033%となる。 (計算式) チロシナーゼ活性阻害率(%)={B−(A−P)}/
B×100 ただし、A:試料検体の吸光度 B:対照の吸光度 P:試料検体の着色による吸光度(3倍希釈)
[Inhibition of Tyrosinase Activity] (Test method) Mcllvaln buffer 0.9m
l, 1.0 ml of 1.66 mM tyrosine solution, 0.1 wt / v% aqueous solution of the above-mentioned preparation (freeze-dried product) (If it is difficult to dissolve, add ethanol and dissolve, then add purified water and evaporate. After removing ethanol, 0.1w
1.0 ml) was placed in a screw vial and heated in a constant temperature water bath at 37 ° C. for 5 minutes or more. Tyrosinase solution (manufactured by Sigma, from mushroom, 914
(Unit / ml) was added, and the solution was kept warm in a constant temperature water bath at 37 ° C., and the absorbance was measured at 475 nm after 10 minutes. As a control, pure water was added instead of the sample solution, and the measurement was performed in the same manner.
In this test, the final concentration of the sample is 0.033%. (Calculation formula) Tyrosinase activity inhibition rate (%) = {B- (AP)} /
B × 100 where A: absorbance of sample specimen B: absorbance of control P: absorbance due to coloring of sample specimen (3 times dilution)

【0018】[0018]

【表1】 [Table 1]

【0019】〔ヒアルロニダーゼ活性抑制試験〕 (試験方法)0.4%ヒアルロン酸ナトリウム0.1M
(pH6.0)リン酸緩衝溶液6gを計量し、37℃の
恒温水槽で5分間放置した後、前記製造例(凍結乾燥
品)の0.1wt/v%水溶液(溶解しにくい場合はエタノ
ールを加えて溶解したのち精製水を加えて、エバポレー
トし、エタノール除去したのち、0.1wt/v%になるよ
うに調製した)1.0mlを加え撹拌し、0.01%ヒア
ルロニダーゼ(シグマ社製 牛睾丸製、タイプI−S)
0.1M(pH6.0)リン酸緩衝液を1ml加えて直
ちに撹拌し、6mlを37℃の恒温水槽に入れたオストワ
ルド粘度計に入れた。これを1分後、5分後、10分
後、20分後、40分後に粘度を測定した。対照とし
て、上記試料液の代わりに純水を加え同様にして測定し
た。この試験では試料の終濃度は、それぞれ検体の濃度
の0.0125%となる。1分後の粘度を100とし
て、それぞれの結果を指数で下記表2〜表4に示す。
[Hyaluronidase activity inhibition test] (Test method) 0.4% sodium hyaluronate 0.1M
(PH 6.0) After weighing out 6 g of a phosphate buffer solution and leaving it to stand in a constant temperature water bath at 37 ° C. for 5 minutes, a 0.1 wt / v% aqueous solution of the above-mentioned production example (freeze-dried product) was added. After adding and dissolving, purified water was added and evaporated, and ethanol was removed. Then, 1.0 ml of the mixture was adjusted to be 0.1 wt / v%), and the mixture was stirred and 0.01% hyaluronidase (Sigma cattle) Made of testicles, type IS)
1 ml of a 0.1 M (pH 6.0) phosphate buffer was added and the mixture was immediately stirred, and 6 ml of the mixture was placed in an Ostwald viscometer placed in a thermostat bath at 37 ° C. After 1 minute, 5 minutes, 10 minutes, 20 minutes, and 40 minutes, the viscosity was measured. As a control, pure water was added in place of the sample solution, and measurement was performed in the same manner. In this test, the final concentration of each sample is 0.0125% of the concentration of the sample. The results are shown in Tables 2 to 4 below as indices, with the viscosity after 1 minute as 100.

【0020】[0020]

【表2】 [Table 2]

【0021】[0021]

【表3】 [Table 3]

【0022】[0022]

【表4】 [Table 4]

【0023】〔活性酸素抑制試験〕活性酸素を抑制する
効果を測定する方法は各種あるが、今回以下の方法を利
用した。 pH7.8 50mMリン酸カリウム緩衝液(1.3mM DETAPAC含有) 133ml 40 unit/ml カタラーゼの上記のリン酸カリウム緩衝液 5ml 2mM ニトロブルーテトラゾリウムの上記のリン酸カリウム緩衝液 5ml 1.8mM キサンチンの上記のリン酸カリウム緩衝液 17ml 160ml
[Active Oxygen Suppression Test] There are various methods for measuring the effect of suppressing active oxygen, and the following method was used this time. pH7.8 50 mM potassium phosphate buffer (containing 1.3 mM DETAPAC) 133 ml 40 unit / ml above potassium phosphate buffer with catalase 5 ml 2 mM above potassium phosphate buffer with nitroblue tetrazolium 5 ml 1.8 mM xanthin above phosphorus Potassium acid buffer 17ml 160ml

【0024】上記の試薬の混合物を2.4ml、検体を0.3ml
加えてキサンチンオキシナーゼ(予め検体を水とし、実
験するとき、吸光度が1分当たり0.02前後上昇するよう
に上記のリン酸カリウム緩衝液で調整しておく)液を0.
1ml加えて直ちに吸光度(560nm)を測定する(測定は2
分位し、直線性を確認する)。 (計算式) 阻害率={(A−B)/A}×100 ただし、A:検体を水としたときの1分当たりの吸光度
の変化 B:検体の1分当たりの吸光度の変化 濃度段階を数段階行い、50%活性酸素生成阻害濃度を
探した。検体の作成方法は前記製造例(凍結乾燥品)を
適当な濃度の水溶液を調製(溶解しにくい場合はエタノ
ールを加えて溶解したのち精製水を加えて、エバポレー
トし、エタノールを除去したのち適当な濃度%となるよ
うに調製)した。
2.4 ml of the above mixture of reagents and 0.3 ml of the specimen
In addition, a xanthine oxynase (water is used as a sample in advance, and when the experiment is performed, the absorbance is adjusted with the above potassium phosphate buffer so that the absorbance increases by about 0.02 per minute).
Immediately after adding 1 ml, measure the absorbance (560 nm).
Quantile and confirm linearity). (Calculation formula) Inhibition rate = {(AB) / A} × 100 where A: change in absorbance per minute when the sample is water B: change in absorbance per minute of sample Several steps were performed to find a 50% active oxygen production inhibiting concentration. A sample was prepared by preparing an aqueous solution of the above-mentioned production example (freeze-dried product) at an appropriate concentration (if it is difficult to dissolve, add ethanol to dissolve it, add purified water, evaporate, remove ethanol, and Concentration).

【0025】[0025]

【表5】 [Table 5]

【0026】〔抗酸化試験〕下記のネジキャップ付50
ml試験管を作製した。 検体 5ml 2%リノール酸エタノール溶液 10ml 0.1M、pH7.0リン酸緩衝液 10ml 精製水 5ml このネジキャップ付50ml試験管を50℃の恒温槽に遮
光して放置する。これを恒温槽に入れる前、4日後、7
日後、11日後に下記の測定をした。試験液0.125
ml、75%エタノール12.125ml、30%チオ
シアン酸アンモニウム0.125mlを加えて撹拌し3
分間放置後、0.02N塩化第一鉄3.5%HCL水溶
液0.125mlを加えて撹拌し3分間放置後、500
nmで吸光度を測定した。セル長10mm、対照セルは
試験液を水に置き換えたもの。
[Antioxidant test] 50 with the following screw cap
An ml test tube was prepared. Specimen 5 ml 2% linoleic acid ethanol solution 10 ml 0.1 M, pH 7.0 phosphate buffer 10 ml purified water 5 ml This 50 ml test tube with a screw cap is left in a constant temperature bath at 50 ° C. while being shielded from light. Before putting it in a thermostat, 4 days later, 7
The following measurements were taken after 11 days. Test solution 0.125
ml, 12.125 ml of 75% ethanol, and 0.125 ml of 30% ammonium thiocyanate.
0.125 ml of a 0.02 N ferrous chloride 3.5% HCl aqueous solution was added, and the mixture was stirred.
The absorbance was measured in nm. The cell length was 10 mm, and the control cell was one in which the test solution was replaced with water.

【0027】[0027]

【表6】 [Table 6]

【0028】[0028]

【表7】 [Table 7]

【0029】(使用テスト)女性6名の顔面を左右に分
け、一方に、実施例のローションとクリームをセットに
して、他方には比較例のローションとクリームをセット
にして毎日、1回以上使用してもらって、3カ月後に、
美白、肌荒れ防止、肌のつや及び肌のはりについて評価
した。なお、比較例は実施例より製造例の各種のオオバ
ナサルスベリの抽出物を水に代えたものである(比較例
1、2)。なお、12名を2班にわけ、下記表8に示さ
れる試料を使って試験した。
(Usage test) The face of six women was divided into left and right, and the lotion and cream of the example were set on one side, and the lotion and cream of the comparative example were set on the other side, and used at least once a day. After three months,
Evaluation was made on whitening, prevention of rough skin, luster of the skin, and skin swelling. In Comparative Examples, water extract was used in place of various extracts of Pseudomonas japonicus in Preparation Examples from Examples (Comparative Examples 1 and 2). In addition, 12 persons were divided into two groups and tested using the samples shown in Table 8 below.

【0030】[0030]

【表8】 [Table 8]

【0031】評価は、下記の評価基準により評価し、そ
の結果をまとめたのが下記の表9である。 (評価基準) 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3
The evaluation was performed according to the following evaluation criteria, and the results are summarized in Table 9 below. (Evaluation criteria) Example is very good 3 Example is considerably better 2 Example is slightly better 1 No difference 0 Comparative example is slightly better -1 Comparative example is much better − 2 Comparative example is much better -3

【0032】[0032]

【表9】 [Table 9]

【0033】上記チロシナーゼの活性抑制試験結果(表
1)、ヒアルロニダーゼ活性抑制試験結果(表2〜表
4)、活性酸素抑制試験結果(表5)、抗酸化試験(表
6及び表7)、使用テスト(表9)から明らかなよう
に、本発明のオオバナサルスベリの溶媒抽出物を含む化
粧料は、チロシナーゼの活性、ヒアルロニダーゼの活性
及び活性酸素を抑制し、美白、肌荒れ防止、肌のつや及
び肌のはりに有効なことが判った。
Results of the tyrosinase activity suppression test (Table 1), hyaluronidase activity suppression test results (Tables 2 to 4), active oxygen suppression test results (Table 5), antioxidant tests (Tables 6 and 7), use As is clear from the test (Table 9), the cosmetic containing the solvent extract of Streptomyces cerevisiae according to the present invention suppresses the activity of tyrosinase, the activity of hyaluronidase and active oxygen, and prevents whitening, rough skin, luster and skin. It turned out to be effective for the beam.

【0034】[0034]

【発明の効果】本発明によれば、美白作用が高く、ヒア
ルロニダーゼの活性を抑制し、且つ肌荒れなどに有効な
安全性の高い化粧料が提供される。
According to the present invention, there is provided a highly safe cosmetic which has a high whitening effect, suppresses the activity of hyaluronidase, and is effective for rough skin.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 下村 健次 三重県伊勢市船江3−16−32 (72)発明者 中村 雅美 三重県鳥羽市池上町6−32 (56)参考文献 特開 平3−201969(JP,A) 特開 平5−310587(JP,A) 特開 昭52−82711(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 ──────────────────────────────────────────────────続 き Continuation of the front page (72) Inventor Kenji Shimomura 3-16-32 Funae, Ise City, Mie Prefecture (72) Inventor Masami Nakamura 6-32, Ikegami-cho, Toba City, Mie Prefecture (56) References JP-A-3-3 201969 (JP, A) JP-A-5-310587 (JP, A) JP-A-52-82711 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 7/00-7 / 50

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 オオバナサルスベリ(lagerstroemia sp
eciosa)の溶媒抽出物を含む化粧料。
[Claim 1] Lagerstroemia sp.
cosmetics containing a solvent extract of eciosa).
JP27690593A 1993-11-05 1993-11-05 Cosmetics Expired - Fee Related JP3235922B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27690593A JP3235922B2 (en) 1993-11-05 1993-11-05 Cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27690593A JP3235922B2 (en) 1993-11-05 1993-11-05 Cosmetics

Publications (2)

Publication Number Publication Date
JPH07126143A JPH07126143A (en) 1995-05-16
JP3235922B2 true JP3235922B2 (en) 2001-12-04

Family

ID=17576027

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27690593A Expired - Fee Related JP3235922B2 (en) 1993-11-05 1993-11-05 Cosmetics

Country Status (1)

Country Link
JP (1) JP3235922B2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3487619B2 (en) * 1993-11-17 2004-01-19 御木本製薬株式会社 5α-reductase inhibitor
JP2000302634A (en) * 1999-04-27 2000-10-31 Ichimaru Pharcos Co Ltd Cosmetic composition
JP4094332B2 (en) * 2002-04-23 2008-06-04 丸善製薬株式会社 Water dispersible or water soluble banaba leaf extract composition
KR100507915B1 (en) * 2002-11-04 2005-08-09 주식회사 태평양 Cosmetic composition containing lagerstroemia indica flower extract for repairing wrinkle and roughness of the skin
KR100899712B1 (en) * 2008-11-04 2009-05-28 주식회사 일신웰스 Antioxidant composition comprising fermented banaba extract
JP2005350453A (en) * 2004-05-14 2005-12-22 Toyo Shinyaku:Kk Slightly water-soluble component of leaf of lagerstroemia speciosa l.
JP5737663B2 (en) * 2011-04-22 2015-06-17 大学共同利用機関法人自然科学研究機構 Skin barrier function improver
EP2799082B1 (en) * 2011-12-30 2016-12-14 Korea Research Institute of Bioscience and Biotechnology Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient

Also Published As

Publication number Publication date
JPH07126143A (en) 1995-05-16

Similar Documents

Publication Publication Date Title
JPH0967266A (en) Inhibitor of hyaluronidase
JP3193441B2 (en) Whitening cosmetics
JPH07101871A (en) Promoter for synthesis of hyaluronic acid in living body
JPH07277939A (en) Skin external preparation
JP3235922B2 (en) Cosmetics
JP3558349B2 (en) Whitening cosmetics
JP3170040B2 (en) Whitening cosmetics
JP3235919B2 (en) Cosmetics
JP3273812B2 (en) Cosmetics
JPH06336422A (en) External agent for skin
DE102007024679B4 (en) Use of cosmetically active agents to protect FGF-2
JPH069422A (en) Promoter for biosynthesis of hyaluronic acid
JPH10114670A (en) Composition suitable for external use
JP3496967B2 (en) Antiplasmin agent
JP3667376B2 (en) Hyaluronidase inhibitor
JP3176983B2 (en) Whitening cosmetics
JP3206952B2 (en) Antioxidant
JP3545057B2 (en) Cosmetics
JP3233504B2 (en) Cosmetics
KR20180124443A (en) Cosmetic composition for enhancing skin barrier containing extract of Tremella fuciformis fruiting body
JP3461921B2 (en) Cosmetics
JP3423074B2 (en) Cosmetics
JPH05124952A (en) Cosmetic
JP3792745B2 (en) Tyrosinase inhibitor
WO1999009945A1 (en) Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100928

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100928

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130928

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees